Format

Send to

Choose Destination
Cancer Lett. 1994 Apr 1;78(1-3):1-5.

Butyrate as a differentiating agent: pharmacokinetics, analogues and current status.

Author information

1
Laboratory of Digestive Tract Carcinogenesis, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

Abstract

The field of butyrate-induced differentiation of neoplastic and non-neoplastic cells is reviewed and possible clinical correlations considered with regard to butyrate, butyrate prodrugs and butyrate analogues. These topics are discussed from the point of view of the concentrations required in vitro for biologic effect, and likely pharmacokinetic behavior in vivo.

PMID:
8180951
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center